What are the soap and admitting orders for a 2-year-old female patient weighing 10kg with a 1-month history of productive cough, diagnosed with community-acquired pneumonia (PCAP C) and bronchopneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

SOAP and Admitting Orders for 2-Year-Old with Community-Acquired Pneumonia

SOAP Note

Subjective

  • 2-year-old female, 10 kg
  • Chief Complaint: 1-month productive cough
  • History of Present Illness: Prolonged productive cough for 1 month, now with radiographic confirmation of bronchopneumonia 1
  • Review of Systems: Document presence/absence of fever, respiratory distress, feeding difficulties, lethargy, and any recent sick contacts 1

Objective

  • Weight: 10 kg
  • Vital Signs Required:
    • Temperature (fever >38.5°C suggests bacterial etiology) 1
    • Respiratory rate (>50/min in this age group indicates severity) 1
    • Oxygen saturation (SpO2 <92% requires hospitalization) 1
    • Heart rate (assess for sustained tachycardia) 1
    • Blood pressure 1
  • Physical Examination:
    • Assess for chest retractions, nasal flaring, grunting 1
    • Auscultate for crackles, decreased breath sounds, wheezing (wheeze suggests viral etiology) 1
    • Evaluate work of breathing and general appearance 1
  • Imaging: CXR showing bronchopneumonia (already obtained) 1

Assessment

Primary Diagnosis: Community-acquired pneumonia (bacterial, presumed) with bronchopneumonia pattern in a 2-year-old 1

Severity Assessment: This child requires hospitalization given the 1-month duration suggesting treatment failure or complicated course, warranting inpatient management 1

Plan

Proceed to admitting orders below.


Admitting Orders

1. Admission Status

  • Admit to: Pediatric ward with continuous pulse oximetry monitoring 1
  • Admit to ICU if: SpO2 <92% on FiO2 ≥0.50, impending respiratory failure, altered mental status, or need for positive pressure ventilation 1

2. Diagnosis

  • Community-acquired pneumonia (bacterial, presumed) 1

3. Condition

  • Stable/guarded (depending on clinical presentation)

4. Vital Signs

  • Every 4 hours minimum including continuous pulse oximetry 1
  • Monitor for: temperature, heart rate, respiratory rate, blood pressure, oxygen saturation 1

5. Activity

  • Bed rest with minimal handling to reduce oxygen requirements 1

6. Diet

  • Age-appropriate diet as tolerated 1
  • NPO if: severe respiratory distress or vomiting 1
  • Avoid nasogastric tubes in severely ill children as they may compromise breathing; if absolutely necessary, use smallest tube in smallest nostril 1

7. IV Fluids

  • Maintenance fluids at 80% of basal requirements 1, 2
  • For 10 kg child: approximately 800 mL/24 hours (33 mL/hour) of D5 0.45% NaCl
  • Monitor serum electrolytes 1, 2

8. Oxygen Therapy

  • Supplemental oxygen to maintain SpO2 >92% via nasal cannula, head box, or face mask 1, 2
  • Titrate FiO2 as needed 1

9. Medications

Antibiotic Therapy (Primary Treatment)

For this 2-year-old (10 kg) with presumed bacterial pneumonia requiring hospitalization:

Ampicillin 250 mg IV every 6 hours (100 mg/kg/day divided q6h) 1

  • Alternative: Ceftriaxone 500 mg IV once daily (50 mg/kg/day, max 2g) 1
  • Alternative: Cefotaxime 500 mg IV every 8 hours (150 mg/kg/day divided q8h) 1

Rationale: This child is fully immunized (assumed standard vaccination schedule), making ampicillin or penicillin G appropriate first-line therapy for hospitalized patients 1. The prolonged 1-month course raises concern for possible atypical pathogen or treatment failure.

Add Azithromycin 100 mg IV/PO once daily (10 mg/kg on day 1, then 5 mg/kg days 2-5) if atypical pneumonia cannot be excluded 1, 3

Add Vancomycin 150 mg IV every 6 hours (60 mg/kg/day divided q6h) OR Clindamycin 100 mg IV every 6 hours (40 mg/kg/day divided q6-8h) if CA-MRSA suspected (necrotizing pneumonia, empyema, severe illness) 1

Supportive Medications

  • Acetaminophen 150 mg PO/PR every 4-6 hours PRN fever >38.5°C or discomfort (15 mg/kg/dose) 1, 2
  • Ibuprofen 100 mg PO every 6-8 hours PRN fever or pain (10 mg/kg/dose) 1

10. Laboratory Studies

  • Blood cultures x2 (from separate sites) BEFORE starting antibiotics 1
  • Complete blood count with differential 2
  • Basic metabolic panel (baseline and to monitor electrolytes with IV fluids) 1
  • Save acute serum sample for possible convalescent titers if diagnosis unclear 1
  • Nasopharyngeal aspirate for viral testing (RSV, influenza, other respiratory viruses) given age <18 months 1
  • Consider: Blood gas if severe respiratory distress 1

11. Nursing Orders

  • Skilled pediatric nursing care 1
  • Pulse oximetry continuous 1
  • Strict intake and output 1
  • Notify physician if:
    • SpO2 <92% on current oxygen therapy 1
    • Respiratory rate >70/min 1
    • Temperature >39°C or <36°C 1
    • Increased work of breathing, grunting, or apnea 1
    • Altered mental status 1
    • Inadequate oral intake 1

12. Respiratory Care

  • NO chest physiotherapy (not beneficial and should not be performed) 1, 2
  • Encourage coughing and deep breathing when comfortable 1

13. Monitoring and Follow-up

  • Reassess clinical status at 48-72 hours for expected improvement 1, 4
  • If no improvement or deterioration at 48-72 hours:
    • Repeat blood cultures 1
    • Consider chest ultrasound or repeat CXR to evaluate for complications (parapneumonic effusion, empyema, lung abscess) 1
    • Broaden antibiotic coverage 1
    • Consider alternative diagnoses (immunodeficiency, foreign body, tuberculosis) 1

14. Transition to Oral Therapy

  • Switch from IV to oral antibiotics when:
    • Clear clinical improvement (decreased fever, improved respiratory status) 1
    • Tolerating oral intake 1
    • Typically after 24-48 hours of clinical stability 1
  • Oral regimen: Amoxicillin 450 mg PO twice daily (90 mg/kg/day in 2 doses) to complete 7-10 day total course 1

15. Discharge Planning

  • Discharge criteria:
    • Afebrile for 24 hours 4
    • SpO2 >92% on room air 1
    • Tolerating oral intake and medications 1
    • Reliable follow-up available 1
  • Follow-up: Outpatient visit in 48-72 hours post-discharge 1, 2
  • Repeat CXR only if: Lobar collapse, round pneumonia appearance, or persistent symptoms at follow-up 1, 2

Key Clinical Pitfalls

The 1-month duration of symptoms is concerning and suggests either:

  • Initial viral infection with secondary bacterial superinfection 4
  • Inadequate outpatient antibiotic therapy (wrong drug, wrong dose, or resistant organism) 1
  • Complicated pneumonia (empyema, abscess) 1
  • Alternative diagnosis (foreign body aspiration, tuberculosis, immunodeficiency) 1

This prolonged course mandates hospitalization even if current vital signs are stable, as it indicates treatment failure requiring IV antibiotics and close monitoring 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic and Treatment Approach for Pediatric Pneumonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Viral Pneumonia in Pediatrics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.